{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:50:16Z","timestamp":1790553016382,"version":"4.1.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cell Biol"],"DOI":"10.1186\/1471-2121-3-22","type":"journal-article","created":{"date-parts":[[2002,9,26]],"date-time":"2002-09-26T12:07:27Z","timestamp":1033042047000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["The F-box protein SKP2 mediates androgen control of p27 stability in LNCaP human prostate cancer cells"],"prefix":"10.1186","volume":"3","author":[{"given":"Lifang","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter A","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2002,8,20]]},"reference":[{"key":"51_CR1","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0002-9440(10)65632-5","volume":"153","author":"AM De Marzo","year":"1998","unstructured":"De Marzo AM, Meeker AK, Epstein JI, Coffey DS: Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am J Pathol. 1998, 153: 911-9.","journal-title":"Am J Pathol"},{"key":"51_CR2","first-page":"324","volume":"11","author":"JC Cheville","year":"1998","unstructured":"Cheville JC, Lloyd RV, Sebo TJ, Cheng L, Erickson L, Bostwick DG, Lohse CM, Wollan P: Expression of p27kip1 in prostatic adenocarcinoma. Mod Pathol. 1998, 11: 324-8.","journal-title":"Mod Pathol"},{"key":"51_CR3","first-page":"542","volume":"58","author":"J Tsihlias","year":"1998","unstructured":"Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM: Loss of cyclin-dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res. 1998, 58: 542-8.","journal-title":"Cancer Res"},{"key":"51_CR4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/jnci\/90.12.916","volume":"90","author":"RJ Cote","year":"1998","unstructured":"Cote RJ, Shi Y, Groshen S, Feng AC, Cordon-Cardo C, Skinner D, Lieskovosky G: Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma. J Natl Cancer Inst. 1998, 90: 916-20. 10.1093\/jnci\/90.12.916.","journal-title":"J Natl Cancer Inst"},{"key":"51_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/380262a0","volume":"380","author":"A Mal","year":"1996","unstructured":"Mal A, Poon RY, Howe PH, Toyoshima H, Hunter T, Harter ML: Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells. Nature. 1996, 380: 262-5. 10.1038\/380262a0.","journal-title":"Nature"},{"key":"51_CR6","first-page":"2323","volume":"13","author":"K Zerfass-Thome","year":"1996","unstructured":"Zerfass-Thome K, Zwerschke W, Mannhardt B, Tindle R, Botz JW, Jansen-Durr P: Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene. 1996, 13: 2323-30.","journal-title":"Oncogene"},{"key":"51_CR7","first-page":"2266","volume":"55","author":"N Kawamata","year":"1995","unstructured":"Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilcyznski S: Molecular analysis of the cyclin-dependent kinase inhibitor gene p27\/Kip1 in human malignancies. Cancer Res. 1995, 55: 2266-9.","journal-title":"Cancer Res"},{"key":"51_CR8","first-page":"1211","volume":"55","author":"MV Ponce-Castaneda","year":"1995","unstructured":"Ponce-Castaneda MV, Lee MH, Latres E, Polyak K, Lacombe L, Montgomery K, Mathew S, Krauter K, Sheinfeld J, Massague J: p27Kip1: chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res. 1995, 55: 1211-4.","journal-title":"Cancer Res"},{"key":"51_CR9","first-page":"1206","volume":"55","author":"JA Pietenpol","year":"1995","unstructured":"Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Liu B, Friedman C, Trask BJ, Roberts JM, Kinzler KW, Rowley JD: Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res. 1995, 55: 1206-10.","journal-title":"Cancer Res"},{"key":"51_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/978-1-4615-1809-9_11","volume":"1","author":"A Koff","year":"1995","unstructured":"Koff A, Polyak K: p27KIP1, an inhibitor of cyclin-dependent kinases. Prog Cell Cycle Res. 1995, 1: 141-7.","journal-title":"Prog Cell Cycle Res"},{"key":"51_CR11","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","volume":"9","author":"CJ Sherr","year":"1995","unstructured":"Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 1995, 9: 1149-63.","journal-title":"Genes Dev"},{"key":"51_CR12","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.272.5263.877","volume":"272","author":"S Coats","year":"1996","unstructured":"Coats S, Flanagan WM, Nourse J, Roberts JM: Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science. 1996, 272: 877-80.","journal-title":"Science"},{"key":"51_CR13","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1126\/science.271.5257.1861","volume":"271","author":"L Hengst","year":"1996","unstructured":"Hengst L, Reed SI: Translational control of p27Kip1 accumulation during the cell cycle. Science. 1996, 271: 1861-4.","journal-title":"Science"},{"key":"51_CR14","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1093\/jnci\/90.17.1284","volume":"90","author":"C Cordon-Cardo","year":"1998","unstructured":"Cordon-Cardo C, Koff A, Drobnjak M, Capodieci P, Osman I, Millard SS, Gaudin PB, Fazzari M, Zhang ZF, Massague J, Scher HI: Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma. J Natl Cancer Inst. 1998, 90: 1284-91. 10.1093\/jnci\/90.17.1284.","journal-title":"J Natl Cancer Inst"},{"key":"51_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nm0297-231","volume":"3","author":"M Loda","year":"1997","unstructured":"Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat Med. 1997, 3: 231-4.","journal-title":"Nat Med"},{"key":"51_CR16","first-page":"3381","volume":"57","author":"V Esposito","year":"1997","unstructured":"Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M, Giordano A: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res. 1997, 57: 3381-5.","journal-title":"Cancer Res"},{"key":"51_CR17","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V95.2.619","volume":"95","author":"R Chiarle","year":"2000","unstructured":"Chiarle R, Budel LM, Skolnik J, Frizzera G, Chilosi M, Corato A, Pizzolo G, Magidson J, Montagnoli A, Pagano M, Maes B, De Wolf-Peeters C, Inghirami G: Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood. 2000, 95: 619-26.","journal-title":"Blood"},{"key":"51_CR18","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/00005072-199907000-00002","volume":"58","author":"R Piva","year":"1999","unstructured":"Piva R, Cancelli I, Cavalla P, Bortolotto S, Dominguez J, Draetta GF, Schiffer D: Proteasome-dependent degradation of p27\/kip1 in gliomas. J Neuropathol Exp Neurol. 1999, 58: 691-6.","journal-title":"J Neuropathol Exp Neurol"},{"key":"51_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","volume":"67","author":"A Hershko","year":"1998","unstructured":"Hershko A, Ciechanover A: The ubiquitin system. Annu Rev Biochem. 1998, 67: 425-79. 10.1146\/annurev.biochem.67.1.425.","journal-title":"Annu Rev Biochem"},{"key":"51_CR20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/12013","volume":"1","author":"AC Carrano","year":"1999","unstructured":"Carrano AC, Eytan E, Hershko A, Pagano M: SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol. 1999, 1: 193-199. 10.1038\/12013.","journal-title":"Nat Cell Biol"},{"key":"51_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/S0960-9822(99)80290-5","volume":"9","author":"LM Tsvetkov","year":"1999","unstructured":"Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H: p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr Biol. 1999, 9: 661-4. 10.1016\/S0960-9822(99)80290-5.","journal-title":"Curr Biol"},{"key":"51_CR22","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/S1097-2765(01)00210-6","volume":"7","author":"C Spruck","year":"2001","unstructured":"Spruck C, Strohmaier H, Watson M, Smith AP, Ryan A, Krek TW, Reed SI: A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1. Mol Cell. 2001, 7: 639-50.","journal-title":"Mol Cell"},{"key":"51_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/35060126","volume":"3","author":"D Ganoth","year":"2001","unstructured":"Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, Hershko A: The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol. 2001, 3: 321-4. 10.1038\/35060126.","journal-title":"Nat Cell Biol"},{"key":"51_CR24","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1101\/gad.11.11.1464","volume":"11","author":"RJ Sheaff","year":"1997","unstructured":"Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE: Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev. 1997, 11: 1464-78.","journal-title":"Genes Dev"},{"key":"51_CR25","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.1093\/emboj\/16.17.5334","volume":"16","author":"J Vlach","year":"1997","unstructured":"Vlach J, Hennecke S, Amati B: Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27. Embo J. 1997, 16: 5334-44. 10.1093\/emboj\/16.17.5334.","journal-title":"Embo J"},{"key":"51_CR26","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1101\/gad.13.9.1181","volume":"13","author":"A Montagnoli","year":"1999","unstructured":"Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M: Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev. 1999, 13: 1181-9.","journal-title":"Genes Dev"},{"key":"51_CR27","first-page":"435","volume":"9","author":"JJ Michel","year":"1998","unstructured":"Michel JJ, Xiong Y: Human CUL-1, but not other cullin family members, selectively interacts with SKP1 to form a complex with SKP2 and cyclin A. Cell Growth Differ. 1998, 9: 435-49.","journal-title":"Cell Growth Differ"},{"key":"51_CR28","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1093\/emboj\/17.2.368","volume":"17","author":"J Lisztwan","year":"1998","unstructured":"Lisztwan J, Marti A, Sutterluty H, Gstaiger M, Wirbelauer C, Krek W: Association of human CUL-1 and ubiquitin-conjugating enzyme CDC34 with the F-box protein p45(SKP2): evidence for evolutionary conservation in the subunit composition of the CDC34-SCF pathway. Embo J. 1998, 17: 368-83. 10.1093\/emboj\/17.2.368.","journal-title":"Embo J"},{"key":"51_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/12027","volume":"1","author":"H Sutterluty","year":"1999","unstructured":"Sutterluty H, Chatelain E, Marti A, Wirbelauer C, Senften M, Muller U, Krek W: p45Skp2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat. Cell Biol. 1999, 1: 207-214. 10.1038\/12027.","journal-title":"Nat. Cell Biol"},{"key":"51_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0960-9822(01)00065-3","volume":"11","author":"R Mamillapalli","year":"2001","unstructured":"Mamillapalli R, Gavrilova N, Mihaylova VT, Tsvetkov LM, Wu H, Zhang H, Sun H: PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2). Curr Biol. 2001, 11: 263-7. 10.1016\/S0960-9822(01)00065-3.","journal-title":"Curr Biol"},{"key":"51_CR31","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1038\/sj.onc.1204248","volume":"20","author":"CJ Nelsen","year":"2001","unstructured":"Nelsen CJ, Hansen LK, Rickheim DG, Chen C, Stanley MW, Krek W, Albrecht JH: Induction of hepatocyte proliferation and liver hyperplasia by the targeted expression of cyclin E and skp2. Oncogene. 2001, 20: 1825-31. 10.1038\/sj.onc.1204248.","journal-title":"Oncogene"},{"key":"51_CR32","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1083\/jcb.153.7.1381","volume":"153","author":"AC Carrano","year":"2001","unstructured":"Carrano AC, Pagano M: Role of the F-box protein Skp2 in adhesion-dependent cell cycle progression. J Cell Biol. 2001, 153: 1381-90. 10.1083\/jcb.153.7.1381.","journal-title":"J Cell Biol"},{"key":"51_CR33","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1073\/pnas.081474898","volume":"98","author":"M Gstaiger","year":"2001","unstructured":"Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, Krek W: Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A. 2001, 98: 5043-8. 10.1073\/pnas.081474898.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"51_CR34","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1073\/pnas.041475098","volume":"98","author":"E Latres","year":"2001","unstructured":"Latres E, Chiarle R, Schulman BA, Pavletich NP, Pellicer A, Inghirami G, Pagano M: Role of the F-box protein Skp2 in lymphomagenesis. Proc Natl Acad Sci U S A. 2001, 98: 2515-20. 10.1073\/pnas.041475098.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"51_CR35","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/0092-8674(95)90271-6","volume":"82","author":"H Zhang","year":"1995","unstructured":"Zhang H, Kobayashi R, Galaktionov K, Beach D: p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell. 1995, 82: 915-25.","journal-title":"Cell"},{"key":"51_CR36","first-page":"985","volume":"58","author":"Y Chao","year":"1998","unstructured":"Chao Y, Shih YL, Chiu JH, Chau GY, Lui WY, Yang WK, Lee SD, Huang TS: Overexpression of cyclin A but not Skp 2 correlates with the tumor relapse of human hepatocellular carcinoma. Cancer Res. 1998, 58: 985-90.","journal-title":"Cancer Res"},{"key":"51_CR37","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/1097-0142(20010501)91:9<1745::AID-CNCR1193>3.0.CO;2-H","volume":"91","author":"D Hershko","year":"2001","unstructured":"Hershko D, Bornstein G, Ben-Izhak O, Carrano A, Pagano M, Krausz MM, Hershko A: Inverse relation between levels of p27(Kip1) and of its ubiquitin ligase subunit Skp2 in colorectal carcinomas. Cancer. 2001, 91: 1745-51. 10.1002\/1097-0142(20010501)91:9<1745::AID-CNCR1193>3.0.CO;2-H.","journal-title":"Cancer"},{"key":"51_CR38","first-page":"7044","volume":"61","author":"Y Kudo","year":"2001","unstructured":"Kudo Y, Kitajima S, Sato S, Miyauchi M, Ogawa I, Takata T: High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Cancer Res. 2001, 61: 7044-7.","journal-title":"Cancer Res"},{"key":"51_CR39","first-page":"115","volume":"37","author":"JS Horoszewicz","year":"1980","unstructured":"Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK, Sandberg AA: The LNCaP cell line \u2013 a new model for studies on human prostatic carcinoma. Prog Clin Biol Res. 1980, 37: 115-32.","journal-title":"Prog Clin Biol Res"},{"key":"51_CR40","first-page":"545","volume":"7","author":"AM Soto","year":"1995","unstructured":"Soto AM, Lin TM, Sakabe K, Olea N, Damassa DA, Sonnenschein C: Variants of the human prostate LNCaP cell line as tools to study discrete components of the androgen-mediated proliferative response. Oncol Res. 1995, 7: 545-58.","journal-title":"Oncol Res"},{"key":"51_CR41","first-page":"3474","volume":"49","author":"C Sonnenschein","year":"1989","unstructured":"Sonnenschein C, Olea N, Pasanen ME, Soto AM: Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res. 1989, 49: 3474-81.","journal-title":"Cancer Res"},{"key":"51_CR42","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1210\/mend.12.7.0136","volume":"12","author":"JM Kokontis","year":"1998","unstructured":"Kokontis JM, Hay N, Liao S: Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Mol Endocrinol. 1998, 12: 941-53.","journal-title":"Mol Endocrinol"},{"key":"51_CR43","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/sj.onc.1203369","volume":"19","author":"J Tsihlias","year":"2000","unstructured":"Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J: Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells. Oncogene. 2000, 19: 670-9. 10.1038\/sj.onc.1203369.","journal-title":"Oncogene"},{"key":"51_CR44","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/bjc.1992.76","volume":"65","author":"DA Wolf","year":"1992","unstructured":"Wolf DA, Kohlhuber F, Schulz P, Fittler F, Eick D: Transcriptional down-regulation of c-myc in human prostate carcinoma cells by the synthetic androgen mibolerone. Br J Cancer. 1992, 65: 376-82.","journal-title":"Br J Cancer"},{"key":"51_CR45","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/bbrc.2001.4738","volume":"283","author":"K Hofman","year":"2001","unstructured":"Hofman K, Swinnen JV, Verhoeven G, Heyns W: E2F activity is biphasically regulated by androgens in LNCaP cells. Biochem Biophys Res Commun. 2001, 283: 97-101. 10.1006\/bbrc.2001.4738.","journal-title":"Biochem Biophys Res Commun"},{"key":"51_CR46","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/bjc.1991.237","volume":"64","author":"DA Wolf","year":"1991","unstructured":"Wolf DA, Schulz P, Fittler F: Synthetic androgens suppress the transformed phenotype in the human prostate carcinoma cell line LNCaP. Br J Cancer. 1991, 64: 47-53.","journal-title":"Br J Cancer"},{"key":"51_CR47","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/0092-8674(92)90249-C","volume":"70","author":"PW Hinds","year":"1992","unstructured":"Hinds PW, Mittnacht S, Dulic V, Arnold A, Reed SI, Weinberg RA: Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell. 1992, 70: 993-1006.","journal-title":"Cell"},{"key":"51_CR48","first-page":"1571","volume":"7","author":"Y Chen","year":"1996","unstructured":"Chen Y, Robles AI, Martinez LA, Liu F, Gimenez-Conti IB, Conti CJ: Expression of G1 cyclins, cyclin-dependent kinases, and cyclin-dependent kinase inhibitors in androgen-induced prostate proliferation in castrated rats. Cell Growth Differ. 1996, 7: 1571-8.","journal-title":"Cell Growth Differ"},{"key":"51_CR49","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1210\/mend.15.5.0640","volume":"15","author":"D Waltregny","year":"2001","unstructured":"Waltregny D, Leav I, Signoretti S, Soung P, Lin D, Merk F, Adams JY, Bhattacharya N, Cirenei N, Loda M: Androgen-driven prostate epithelial cell proliferation and differentiation in vivo involve the regulation of p27. Mol Endocrinol. 2001, 15: 765-82.","journal-title":"Mol Endocrinol"},{"key":"51_CR50","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/pros.2990150104","volume":"15","author":"I Leav","year":"1989","unstructured":"Leav I, Merk FB, Kwan PW, Ho SM: Androgen-supported estrogen-enhanced epithelial proliferation in the prostates of intact Noble rats. Prostate. 1989, 15: 23-40.","journal-title":"Prostate"},{"key":"51_CR51","first-page":"4159","volume":"56","author":"RD Mashal","year":"1996","unstructured":"Mashal RD, Lester S, Corless C, Richie JP, Chandra R, Propert KJ, Dutta A: Expression of cell cycle-regulated proteins in prostate cancer. Cancer Res. 1996, 56: 4159-63.","journal-title":"Cancer Res"},{"key":"51_CR52","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0960-0760(97)00122-2","volume":"63","author":"P Geck","year":"1997","unstructured":"Geck P, Szelei J, Jimenez J, Lin TM, Sonnenschein C, Soto AM: Expression of novel genes linked to the androgen-induced, proliferative shutoff in prostate cancer cells. J Steroid Biochem Mol Biol. 1997, 63: 211-8. 10.1016\/S0960-0760(97)00122-2.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"51_CR53","doi-asserted-by":"publisher","first-page":"10185","DOI":"10.1073\/pnas.97.18.10185","volume":"97","author":"P Geck","year":"2000","unstructured":"Geck P, Maffini MV, Szelei J, Sonnenschein C, Soto AM: Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator. Proc Natl Acad Sci U S A. 2000, 97: 10185-90. 10.1073\/pnas.97.18.10185.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"51_CR54","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/18230","volume":"398","author":"K Tomoda","year":"1999","unstructured":"Tomoda K, Y. K, J.-Y. K: Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature. 1999, 398: 160-5. 10.1038\/18230.","journal-title":"Nature"},{"key":"51_CR55","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1074\/jbc.M104431200","volume":"277","author":"K Tomoda","year":"2002","unstructured":"Tomoda K, Kubota Y, Arata Y, Mori S, Maeda M, Tanaka T, Yoshida M, Yoneda-Kato N, Kato JY: The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1\/CSN5 and the COP9 signalosome complex. J Biol Chem. 2002, 277: 2302-10. 10.1074\/jbc.M104431200.","journal-title":"J Biol Chem"},{"key":"51_CR56","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0092-8674(00)80082-3","volume":"86","author":"DA Chamovitz","year":"1996","unstructured":"Chamovitz DA, Wei N, Osterlund MT, von Arnim AG, Staub JM, Matsui M, Deng XW: The COP9 complex, a novel multisubunit nuclear regulator involved in light control of a plant developmental switch. Cell. 1996, 86: 115-21.","journal-title":"Cell"},{"key":"51_CR57","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0092-8674(00)81603-7","volume":"94","author":"MH Glickman","year":"1998","unstructured":"Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z, Baumeister W, Fried VA, Finley D: A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell. 1998, 94: 615-23.","journal-title":"Cell"},{"key":"51_CR58","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fasebj.12.6.469","volume":"12","author":"M Seeger","year":"1998","unstructured":"Seeger M, Kraft R, Ferrell K, Bech-Otschir D, Dumdey R, Schade R, Gordon C, Naumann M, Dubiel W: A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits. Faseb J. 1998, 12: 469-78.","journal-title":"Faseb J"},{"key":"51_CR59","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0092-8674(94)90578-9","volume":"78","author":"N Wei","year":"1994","unstructured":"Wei N, Chamovitz DA, Deng XW: Arabidopsis COP9 is a component of a novel signaling complex mediating light control of development. Cell. 1994, 78: 117-24.","journal-title":"Cell"},{"key":"51_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2091-2-7","volume":"2","author":"C Zhou","year":"2001","unstructured":"Zhou C, Seibert V, Geyer R, Rhee E, Lyapina S, Cope G, Deshaies RJ, Wolf DA: The fission yeast COP9\/signalosome is involved in cullin modification by ubiquitin-related Ned8p. BMC Biochemistry. 2001, 2: 7-10.1186\/1472-2091-2-7.","journal-title":"BMC Biochemistry"},{"key":"51_CR61","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1091\/mbc.01-10-0521","volume":"13","author":"KE Mundt","year":"2002","unstructured":"Mundt KE, Liu C, Carr AM: Deletion mutants in COP9\/signalosome subunits in fission yeast Schizosaccharomyces pombe display distinct phenotypes. Mol Biol Cell. 2002, 13: 493-502. 10.1091\/mbc.01-10-0521.","journal-title":"Mol Biol Cell"},{"key":"51_CR62","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1105\/tpc.10.11.1779","volume":"10","author":"SF Kwok","year":"1998","unstructured":"Kwok SF, Solano R, Tsuge T, Chamovitz DA, Ecker JR, Matsui M, Deng XW: Arabidopsis homologs of a c-Jun coactivator are present both in monomeric form and in the COP9 complex, and their abundance is differentially affected by the pleiotropic cop\/det\/fus mutations. Plant Cell. 1998, 10: 1779-90. 10.1105\/tpc.10.11.1779.","journal-title":"Plant Cell"},{"key":"51_CR63","first-page":"4130","volume":"7","author":"L Sui","year":"2001","unstructured":"Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K, Tai Y, Tokuda M: Jab1 Expression Is Associated with Inverse Expression of p27(kip1) and Poor Prognosis in Epithelial Ovarian Tumors. Clin Cancer Res. 2001, 7: 4130-5.","journal-title":"Clin Cancer Res"},{"key":"51_CR64","doi-asserted-by":"publisher","first-page":"48937","DOI":"10.1074\/jbc.M107274200","volume":"276","author":"T Hara","year":"2001","unstructured":"Hara T, Kamura T, Nakayama K, Oshikawa K, Hatakeyama S: Degradation of p27(Kip1) at the G(0)-G(1) transition mediated by a Skp2-independent ubiquitination pathway. J Biol Chem. 2001, 276: 48937-43. 10.1074\/jbc.M107274200.","journal-title":"J Biol Chem"},{"key":"51_CR65","first-page":"2067","volume":"10","author":"DA Wolf","year":"1995","unstructured":"Wolf DA, Hermeking H, Albert T, Herzinger T, Kind P, Eick D: A complex between E2F and the pRb-related protein p130 is specifically targeted by the simian virus 40 large T antigen during cell transformation. Oncogene. 1995, 10: 2067-78.","journal-title":"Oncogene"}],"container-title":["BMC Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2121-3-22.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:26:45Z","timestamp":1726244805000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmolcellbiol.biomedcentral.com\/articles\/10.1186\/1471-2121-3-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8,20]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2002,12]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1186\/1471-2121-3-22","relation":{},"ISSN":["1471-2121"],"issn-type":[{"value":"1471-2121","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8,20]]},"assertion":[{"value":"15 April 2002","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2002","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2002","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"22"}}